“…To overcome this problem, several chemical approaches have been attempted to improve the incorporation of ALA and also its selectivity. One approach has been to use more lipophilic ALA derivatives, such as alkyl or ethyleneglycol esters, which are potential substrates for cellular esterases (Kloek and Beijersbergen, 1996;Gaullier et al, 1997;Berger et al, 2000;Uehlinger et al, 2000), or different delivery systems including dendrimers (Battah et al, 2001Di Venosa et al, 2006), or liposomes (Casas et al, 2002;Casas and Batlle, 2006). 5-Aminolaevulinic acid prodrug ester derivatives have been widely studied (Kloek and Beijersbergen, 1996;Peng et al, 1996;Gaullier et al, 1997;Kloek et al, 1998;Casas et al, 1999;Eleouet et al, 2000;Brunner et al, 2003;Lopez et al, 2004), in particular the methyl and hexyl ester derivatives, and approval has been granted for the treatment of actinic keratosis and basal cell carcinoma using the methyl ester derivative in Europe and Australia.…”